Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells

被引:89
作者
Plata-Salamán, CR [1 ]
Ilyin, SE [1 ]
Gayle, D [1 ]
机构
[1] Univ Delaware, Sch Life & Hlth Sci, Div Mol Biol, Newark, DE 19716 USA
关键词
interleukin; tumor necrosis factor; growth factor; nervous system; neuroimmunology; hypothalamus; cortex; cerebellum; cancer; food intake; feeding; anorexia;
D O I
10.1152/ajpregu.1998.275.2.R566
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Cancer is consistently associated with anorexia. The Lobund-Wistar rat model of prostate cancer exhibits clinical manifestations (including anorexia) that resemble many aspects of the human disease. Cytokines are proposed to be involved in cancer-associated anorexia. Here we investigated mRNA profiles of feeding-modulatory cytokines and neuropeptides in specific brain regions of anorectic Lobund-Wistar rats bearing prostate adenocarcinoma tumor cells. Interleukin (IL)-1 beta system components (ligand, signaling receptor, receptor accessory proteins, receptor antagonist), tumor necrosis factor-alpha, transforming growth factor-beta 1, glycoprotein 130 (IL-6 receptor signal transducer), proopiomelanocortin (POMC, opioid peptide precursor), and neuropeptide Y (NPY) mRNAs were analyzed with sensitive and specific RNase protection assays. The same brain region sample was assayed for all components. The data show that early anorexia in tumor-bearing rats was associated with an upregulation of IL-1 beta mRNA in the brain regions examined (cerebellum, cortex, and hypothalamus). IL-1 receptor antagonist (IL-1Ra) mRNA and IL-1 receptor type I mRNA levels were also significantly increased in the cortex and hypothalamus. All other cytokine components, POMC, or NPY mRNA levels were not significantly different between tumor-bearing and pair-fed (control) rats. IL-1 beta mRNA and IL-1Ra mRNA were also significantly upregulated in the spleen of tumor-bearing rats. These data suggest that 1) IL-1 beta mRNA upregulation in the brain may be relevant to the anorexia exhibited by the tumor-bearing Lobund-Wistar rat and 2) in vivo characterization of cytokine components in discrete brain regions during cancer is necessary to understand underlying molecular mechanisms responsible for cancer-associated neurological manifestations.
引用
收藏
页码:R566 / R573
页数:8
相关论文
共 35 条
[1]   The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors [J].
Baumann, H ;
Morella, KK ;
White, DW ;
Dembski, M ;
Bailon, PS ;
Kim, HK ;
Lai, CF ;
Tartaglia, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8374-8378
[2]   HYPOTHALAMIC CONCENTRATION AND RELEASE OF NEUROPEPTIDE-Y INTO MICRODIALYSATES IS REDUCED IN ANORECTIC TUMOR-BEARING RATS [J].
CHANCE, WT ;
BALASUBRAMANIAM, A ;
DAYAL, R ;
BROWN, J ;
FISCHER, JE .
LIFE SCIENCES, 1994, 54 (24) :1869-1874
[3]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[4]  
GELIN J, 1991, CANCER RES, V51, P880
[5]   MOLECULAR-CLONING AND CHARACTERIZATION OF A 2ND SUBUNIT OF THE INTERLEUKIN-1 RECEPTOR COMPLEX [J].
GREENFEDER, SA ;
NUNES, P ;
KWEE, L ;
LABOW, M ;
CHIZZONITE, PA ;
JU, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :13757-13765
[6]   HIV-1 gp120 modulates hypothalamic cytokine mRNAs in vivo: Implications to cytokine feedback systems [J].
Ilyin, SE ;
PlataSalaman, CR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (02) :514-518
[7]   Regulation of brain interleukin-1 beta (IL-1 beta) system mRNAs in response to pathophysiological concentrations of IL-1 beta in the cerebrospinal fluid [J].
Ilyin, SE ;
Sonti, G ;
Gayle, D ;
PlataSalaman, CR .
JOURNAL OF MOLECULAR NEUROSCIENCE, 1996, 7 (03) :169-181
[8]   Interleukin-1α (IL-1α), IL-1β, IL-1 receptor type I, IL-1 receptor antagonist, and TGF-β1 mRNAs in pediatric astrocytomas, ependymomas, and primitive neuroectodermal tumors [J].
Ilyin, SE ;
Gonzalez-Gomez, I ;
Gilles, FH ;
Plata-Salaman, CR .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1998, 33 (02) :125-137
[9]  
KellokumpuLehtinen P, 1996, INT J CANCER, V66, P515, DOI 10.1002/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO
[10]  
2-6